Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy.
Lina van der StratenAvinash G DinmohamedPeter E WesterweelAnton W LangerakJurgen RiedlJeanette K DoorduijnArnon P KaterMark-David LevinPublished in: Leukemia & lymphoma (2018)